Wells Fargo
BVS icon

Wells Fargo’s Bioventus BVS Stock Holding History

Wells Fargo’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Buy
43,964
+27,033
+160% +$258K ﹤0.01% 4756
2026
Q1 		$155K Sell
16,931
-33,703
-67% -$283K ﹤0.01% 4856
2025
Q4 		$377K Buy
50,634
+21,564
+74% +$155K ﹤0.01% 4683
2025
Q3 		$194K Buy
29,070
+4,494
+18% +$31.2K ﹤0.01% 4946
2025
Q2 		$163K Buy
24,576
+2,510
+11% +$17.8K ﹤0.01% 4890
2025
Q1 		$202K Sell
22,066
-428
-2% -$4.28K ﹤0.01% 4695
2024
Q4 		$236K Buy
22,494
+5,459
+32% +$64.6K ﹤0.01% 4693
2024
Q3 		$204K Buy
17,035
+2,153
+14% +$18.6K ﹤0.01% 4567
2024
Q2 		$85.6K Buy
14,882
+14,626
+5,713% +$80.2K ﹤0.01% 5026
2024
Q1 		$1.33K Buy
256
+4
+2% +$20 ﹤0.01% 6093
2023
Q4 		$1.33K Buy
252
+14
+6% +$55 ﹤0.01% 6162
2023
Q3 		$785 Buy
238
+8
+3% +$28 ﹤0.01% 6253
2023
Q2 		$665 Sell
230
-5,448
-96% -$10.5K ﹤0.01% 6425
2023
Q1 		$6.08K Buy
5,678
+5,160
+996% +$9.87K ﹤0.01% 6001
2022
Q4 		$1.35K Sell
518
-296,927
-100% -$1.3M ﹤0.01% 6096
2022
Q3 		$2.08M Sell
297,445
-12,100
-4% -$94.7K ﹤0.01% 2707
2022
Q2 		$2.11M Buy
309,545
+291,963
+1,661% +$2.98M ﹤0.01% 2739
2022
Q1 		$248K Sell
17,582
-9,842
-36% -$132K ﹤0.01% 4862
2021
Q4 		$398K Sell
27,424
-158,205
-85% -$2.25M ﹤0.01% 4847
2021
Q3 		$2.63M Buy
185,629
+37,127
+25% +$571K ﹤0.01% 3436
2021
Q2 		$2.61M Buy
148,502
+146,094
+6,067% +$2.35M ﹤0.01% 3444
2021
Q1 		$37K Buy
+2,408
New +$34.3K ﹤0.01% 5945

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo's BVS Position: Q2 2026 in Review

Wells Fargo increased its Bioventus (BVS) stake by 160% in Q2 2026, buying an estimated $258K and bringing the position to 43,964 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #4756.

Wells Fargo first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.63M in Q3 2021. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Wells Fargo held 43,964 shares of Bioventus worth $415K as of Q2 2026.
  • Wells Fargo bought 27,033 Bioventus shares in Q2 2026, an estimated $258K.
  • Bioventus made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4756 holding.
  • Wells Fargo first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
  • Wells Fargo's Bioventus position peaked at $2.63M in Q3 2021.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.